跳至主要内容
临床试验/IRCT2017082017756N23
IRCT2017082017756N23已完成2 期

Comparison of vitamin D and placebo application on sonographic, laboratory and some biochemical criteria of fatty liver in overweight and obese children aged between 12 and 18 years

Vice-chancellery of Research and Technology, Birjand University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 18 years(—)
性别
All

入选标准

  • Age between 12 and 18 years; children with overweight and obesity based on Centers for Disease Control and Prevention of the United States; children with fatty liver based on ultrasound criteria; vitamin D deficiency under laboratory test; willingness to collaborate in the study.
  • Exclusion criteria: Children with background diseases including known thyroid dysfunction (hypothyroidism and hyperparathyroidism), diabetes and Cushing's syndrome; chronic use of any drug such as corticosteroids, and weight reducing and weight gain drugs; history of alcoholism and hepatitis induced by other causes (hereditary diseases, viruses, etc.); and unwillingness to continue cooperation in the study.

排除标准

  • 未提供

研究者

发起方
Vice-chancellery of Research and Technology, Birjand University of Medical Sciences

相似试验